XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.1

Note 17 - Earnings Per Share (Tables)

9 Months Ended

Mar. 31, 2025

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

		Three Months Ended								Nine Months Ended
		March 31,								March 31,
		2025				2024				2025				2024
		(in thousands, except share and per share data)
BASIC
Numerators:
Net income (loss) from continuing operations		$	3,940			$	(2,288	)		$	5,698			$	(9,142	)
Net income (loss) from discontinued operations, net of tax			54				(599	)			558				(2,085	)
Net income (loss)		$	3,994			$	(2,887	)		$	6,256			$	(11,227	)
Denominator:
Basic weighted-average common shares outstanding			6,134,634				5,533,555				6,111,550				5,511,089
Per share calculations:
Net income (loss) per share from continuing operations		$	0.64			$	(0.41	)		$	0.93			$	(1.66	)
Net income (loss) per share from discontinued operations, net of tax		$	0.01			$	(0.11	)		$	0.09			$	(0.38	)
Net income (loss) per share		$	0.65			$	(0.52	)		$	1.02			$	(2.04	)

		Three Months Ended								Nine Months Ended
		March 31,								March 31,
		2025				2024				2025				2024
		(in thousands, except share and per share data)
DILUTED: CONTINUING OPERATIONS
Numerator:
Net income (loss) from continuing operations		$	3,940			$	(2,288	)		$	5,698			$	(9,142	)
Adjustment for change in fair value of warrant liabilities			(2,261	)			—				(8,157	)			—
Adjusted numerator - net income (loss) from continuing operations		$	1,679			$	(2,288	)		$	(2,459	)		$	(9,142	)
Denominator:
Basic weighted-average common shares outstanding			6,134,634				5,533,555				6,111,550				5,511,089
Dilutive effect of warrants to purchase common stock			2,060,510				—				2,482,368				—
Dilutive effect of unvested restricted stock			9,309				—				12,095				—
Diluted weighted-average common shares outstanding			8,204,453				5,533,555				8,606,013				5,511,089
Per share calculation:
Net income (loss) per share from continuing operations		$	0.20			$	(0.41	)		$	(0.29	)		$	(1.66	)
DILUTED: DISCONTINUED OPERATIONS
Numerator:
Net income (loss) from discontinued operations, net of tax		$	54			$	(599	)		$	558			$	(2,085	)
Denominator:
Basic weighted-average common shares outstanding			6,134,634				5,533,555				6,111,550				5,511,089
Dilutive effect of warrants to purchase common stock			2,060,510				—				2,482,368				—
Dilutive effect of unvested restricted stock			9,309				—				12,095				—
Diluted weighted-average common shares outstanding			8,204,453				5,533,555				8,606,013				5,511,089
Per share calculation:
Net income (loss) per share from discontinued operations, net of tax		$	0.01			$	(0.11	)		$	0.06			$	(0.38	)
DILUTED: NET INCOME (LOSS)
Numerator:
Net income (loss)		$	3,994			$	(2,887	)		$	6,256			$	(11,227	)
Adjustment for change in fair value of warrant liabilities			(2,261	)			—				(8,157	)			—
Adjusted numerator - net income (loss)		$	1,733			$	(2,887	)		$	(1,901	)		$	(11,227	)
Denominator:
Basic weighted-average common shares outstanding			6,134,634				5,533,555				6,111,550				5,511,089
Dilutive effect of warrants to purchase common stock			2,060,510				—				2,482,368				—
Dilutive effect of unvested restricted stock			9,309				—				12,095				—
Diluted weighted-average common shares outstanding			8,204,453				5,533,555				8,606,013				5,511,089
Per share calculation:
Net income (loss) per share		$	0.21			$	(0.52	)		$	(0.22	)		$	(2.04	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

		Three Months Ended								Nine Months Ended
		March 31,								March 31,
		2025				2024				2025				2024
Warrants to purchase common stock - liability classified (note 16)			3,821,256				6,461,976				3,399,398				6,461,976
Warrants to purchase common stock - equity classified (note 16)			15,571				18,114				15,571				18,114
Employee unvested restricted stock (note 15)			25,223				31,897				22,437				31,897
Employee unvested restricted stock units (note 15)			84				2,336				84				2,336
Employee stock options (note 15)			219,244				146,701				219,244				146,701
Total anti-dilutive securities			4,081,378				6,661,024				3,656,734				6,661,024

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration